Category: Clinical Breakthroughs
-
Updating Red Blood Cell Transfusion Guidelines
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
-
Lurie Cancer Center to Lead Trial for Rare Cancer Patients
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
-
Jet Lag Impairs Performance of Major League Baseball Players
When Major League Baseball players travel in a way that misaligns their internal 24-hour clock with the natural environment and its cycle of sunlight, they suffer negative consequences, according to a recent study.
-
Clinical Trials Evaluate New Treatment for Anal Cancer
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
-
Children Born With Heart Defects at Increased Risk for Epilepsy
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
-
Clinical Trial Assesses Non-Hodgkin Lymphoma Drug
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
-
Antiviral Drug Prevents Recurrence of Hepatitis C in Liver Transplant Patients
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.
-
Testing a New Treatment for Crohn’s Disease
A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.
-
Fellow Quantifies Healthy Years Gained by Avoiding Heart Failure Risk Factors
The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
-
Living After Cancer
Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
